Sign inGet started

Mayer Eldon C. III

Insider CIK 1686952 · RIGL EVP &Chief Commercial Officer · EIGR Ex VP & Chief Commerc. Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EIGR Eiger BioPharmaceuticals, S Sale2023-03-172023-03-211,875$1.07 $2.0K56,073SEC↗
EIGR Eiger BioPharmaceuticals, S Sale2023-03-172023-03-212,520$1.07 $2.7K57,948SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2023-03-012023-03-0398,000— $098,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2023-01-262023-01-3031,500— $031,500SEC↗
EIGR Eiger BioPharmaceuticals, S Sale2022-03-142022-03-141,657$5.60 $9.3K60,468SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2022-03-112022-03-1198,000— $098,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award2022-03-112022-03-1116,000— $062,125SEC↗
EIGR Eiger BioPharmaceuticals, S Sale2022-01-072022-01-111,560$4.95 $7.7K46,125SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2021-07-292021-07-3017,500— $017,500SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2021-03-122021-03-1571,250— $071,250SEC↗
EIGR Eiger BioPharmaceuticals, A Award2021-03-122021-03-1511,875— $047,685SEC↗
EIGR Eiger BioPharmaceuticals, S Sale2021-01-082021-01-111,690$11.68 $19.7K35,810SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2020-01-312020-01-31150,000— $0150,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award2020-01-312020-01-317,500— $037,500SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2020-01-242020-01-305,000$13.52 $67.6K30,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2019-11-182019-11-2075,000— $075,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2019-03-212019-03-2510,000— $010,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2019-03-202019-03-2275,000— $075,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2019-01-232019-01-25200,000— $0200,000SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2018-11-292018-11-304,000$10.21 $40.8K25,000SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2018-11-272018-11-287,500$9.92 $74.4K15,000SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2018-11-262018-11-287,500$9.75 $73.1K7,500SEC↗
RIGL RIGEL PHARMACEUTICALS INC P Buy2018-09-112018-09-1250,000$3.23 $161.5K215,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC P Buy2018-09-102018-09-1250,000$3.28 $164.0K165,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC P Buy2018-08-232018-08-27100,000$2.82 $282.0K115,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2018-05-092018-05-1150,000— $050,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2018-03-142018-03-1610,000— $010,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2018-01-242018-01-26150,000— $0150,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2018-01-052018-01-0925,000— $025,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2017-02-022017-02-0650,000— $050,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2016-10-102016-10-11300,000— $0300,000SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2001-11-282018-11-286,000$10.07 $60.4K21,000SEC↗